Alexion Pharmaceuticals, Inc. · 13 hours ago
AI Insights Innovator Intern (Graduate-Level)
Alexion Pharmaceuticals, Inc. is seeking a Master's student for a 12-week internship role. The intern will build an information repository, develop product concepts, and create and test prototype data products within the Breast MDx team.
BiotechnologyHealth CareMedicalTherapeutics
Responsibilities
Build information repository: Collect and organize insight summaries, including full context of the projects from Breast MDx team members
Design: Develop and socialize product concept, collect user needs and requirements from a broader MDx team to inform prototype design
Build prototype data product
Test basic functionalities: develop simple test cases and work with selected stakeholders to verify accuracy and functionality
Summarize the project and present to the organization stakeholders
Qualification
Required
Master's students majoring Computer Science or a related field
Candidates must have an expected graduation date after August 2026
Data/AI Literacy: Understanding of how AI-powered search or chat tools work; understanding limitations, responsible use, and prompting; willingness to learn quickly
Rapid Prototyping: Demonstrated experience in assembling a working prototype, comfort using available platforms, templates, or low-code tools to demonstrate value
User-Centered Product Thinking: Demonstrated experience in translating needs into simple, useful concepts; prioritizing must-haves vs. nice-to-haves; documenting basic requirements and success criteria
Enthusiasm for collaboration, cross-functional projects, public speaking, and presentation design
US Work Authorization is required at time of application
Ability to report onsite to Gaithersburg, MD site 3 days per week. This role will not provide relocation assistance
Preferred
Project Management & Ownership: Planning a 12 week roadmap, managing tasks and milestones, and keeping stakeholders updated; delivering on time with a concise demo and documentation
Company
Alexion Pharmaceuticals, Inc.
Alexion, AstraZeneca Rare Disease is focused on pioneering new possibilities for the rare disease community.
Funding
Current Stage
Public CompanyTotal Funding
$5.8M2020-12-12Acquired
1999-02-12Post Ipo Equity· $5.8M
1996-02-29IPO
Leadership Team
Recent News
bloomberglaw.com
2025-12-20
Company data provided by crunchbase